Mounjaro 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FW6Q3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,266
Award facts
- Contract value 100% obligated
- $2,266.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,266.02 to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections with an ultimate completion date of May 5, 2025. This firm fixed-price delivery order was awarded on a non-competitive basis and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX. The IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company maintains an extensive portfolio of medical product deliveries through the DLA Medical Supply Chain, including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. This delivery order for Mounjaro, a diabetes medication, is consistent with AmerisourceBergen's demonstrated capability to fulfill specialized pharmaceutical requirements under the DLA's Pharmaceutical Prime Vendor program, which supports the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FW6Q3?
SPE2DB25FW6Q3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 2, 2025.
How much is contract SPE2DB25FW6Q3 worth?
The government has obligated $2,266 on SPE2DB25FW6Q3.
Is contract SPE2DB25FW6Q3 an order under another contract?
Yes. SPE2DB25FW6Q3 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB25FW6Q3 competed?
The extent of competition for SPE2DB25FW6Q3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award